Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.1 - $10.41 $1.02 Million - $1.74 Million
167,000 New
167,000 $1.16 Million
Q2 2023

Aug 10, 2023

BUY
$5.72 - $8.8 $93,104 - $143,237
16,277 New
16,277 $130,000
Q3 2022

Nov 10, 2022

BUY
$4.58 - $9.21 $155,559 - $312,817
33,965 New
33,965 $234,000
Q2 2022

Aug 19, 2022

SELL
$7.06 - $23.63 $5 Million - $16.7 Million
-707,760 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$21.6 - $27.79 $6.16 Million - $7.92 Million
285,030 Added 67.43%
707,760 $16.2 Million
Q4 2021

Feb 11, 2022

SELL
$23.0 - $29.01 $6.75 Million - $8.51 Million
-293,454 Reduced 40.97%
422,730 $11.7 Million
Q3 2021

Nov 15, 2021

BUY
$25.04 - $30.06 $2.52 Million - $3.03 Million
100,762 Added 16.37%
716,184 $19.9 Million
Q2 2021

Aug 16, 2021

BUY
$27.43 - $32.7 $6.04 Million - $7.2 Million
220,040 Added 55.65%
615,422 $18 Million
Q1 2021

May 17, 2021

BUY
$21.37 - $34.38 $7.51 Million - $12.1 Million
351,477 Added 800.54%
395,382 $12.5 Million
Q4 2020

Feb 16, 2021

SELL
$15.31 - $21.12 $1.21 Million - $1.67 Million
-78,914 Reduced 64.25%
43,905 $913,000
Q3 2020

Nov 16, 2020

BUY
$14.88 - $20.13 $751,797 - $1.02 Million
50,524 Added 69.89%
122,819 $1.91 Million
Q2 2020

Aug 14, 2020

BUY
$13.31 - $20.51 $962,246 - $1.48 Million
72,295 New
72,295 $1.32 Million
Q4 2019

Feb 14, 2020

SELL
$18.89 - $31.89 $262,193 - $442,633
-13,880 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$20.88 - $25.66 $6.11 Million - $7.51 Million
-292,557 Reduced 95.47%
13,880 $303,000
Q2 2019

Aug 14, 2019

BUY
$20.52 - $26.45 $2.19 Million - $2.82 Million
106,571 Added 53.32%
306,437 $7.73 Million
Q1 2019

May 15, 2019

SELL
$20.23 - $26.29 $6.94 Million - $9.02 Million
-343,223 Reduced 63.2%
199,866 $4.94 Million
Q4 2018

Feb 14, 2019

BUY
$17.64 - $28.32 $9.58 Million - $15.4 Million
543,089 New
543,089 $10 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.